Latest Period
Q2 2026
CUSIP: 805111101
Latest Period
Q2 2026
Institutions Reporting
178
Shares (Excl. Options)
216,926,914
Price
$6.16
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 178 institutions filings for Q2 2026.
Security key
805111101
Latest holder period
Q2 2026
13F holders
178
13D/G owners
12
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 805111101:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Growth Equity Opportunities 17, LLC | 12% | $87,362,412 | 24,471,264 | Growth Equity Opportunities 17, LLC | 12 Nov 2025 | |||
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | +37% | $123,617,225 | +$48,545,450 | 20,881,288 | +65% | Venrock Healthcare Capital Partners III, L.P. | 31 Dec 2025 |
| Bain Capital Life Sciences Fund II, L.P. | 10% | $55,969,975 | 17,600,621 | Bain Capital Life Sciences Fund II, L.P. | 25 Mar 2025 | |||
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 6.8% | $94,350,000 | 15,000,000 | Farallon Capital Management, L.L.C. | 30 Jun 2026 | |||
| Farallon Capital Partners, L.P. | 6.9% | -31% | $90,445,500 | -$19,831,599 | 15,000,000 | -18% | Dapice Joshua J. | 31 Dec 2025 |
| Flynn James E | 6.7% | $48,441,330 | 13,569,000 | Deerfield Mgmt, L.P. | 30 Oct 2025 | |||
| TCG Crossover GP I, LLC | 6.1% | $73,184,254 | 12,362,205 | TCG Crossover GP I, LLC | 31 Dec 2025 | |||
| BlackRock, Inc. | 5.4% | +12% | $66,069,364 | +$15,933,163 | 10,957,322 | +32% | BlackRock, Inc. | 31 Dec 2025 |
| Frazier Life Sciences Public Fund, L.P. | 4.1% | +5% | $49,390,844 | +$9,458,692 | 8,343,048 | +24% | Frazier Life Sciences Public Fund, L.P. | 31 Dec 2025 |
| Nantahala Capital Management, LLC | 3.6% | -29% | $43,481,115 | -$8,469,105 | 7,344,783 | -16% | Nantahala Capital Management, LLC | 31 Dec 2025 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.2% | $17,431,660 | 5,481,654 | Wellington Management Group LLP | 31 Dec 2024 | |||
| Vestal Point Capital, LP | 2.3% | -67% | $14,333,550 | -$24,133,200 | 4,015,000 | -63% | Vestal Point Capital, LP | 30 Sep 2025 |
As of 30 Jun 2026, 178 institutional investors reported holding 216,926,914 shares of Savara Inc - Common Stock, par value $0.001 per share (the "Shares") (SVRA). This represents 98% of the company’s total 220,588,235 outstanding shares.
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 11% | 24,471,264 | 0% | 9.5% | $150,742,986 |
| Bain Capital Life Sciences Investors, LLC | 8% | 17,600,621 | 0% | 6.4% | $108,419,826 |
| Venrock Adviser, LLC | 6.7% | 14,745,943 | +7.3% | 2.8% | $90,835,009 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 6.2% | 13,569,000 | 0% | 0.87% | $83,585,040 |
| BlackRock, Inc. | 5.7% | 12,494,498 | +11% | 0% | $76,966,107 |
| TCG Crossover Management, LLC | 5.6% | 12,362,205 | 0% | 1.8% | $76,151,183 |
| Frazier Life Sciences Management, L.P. | 4.4% | 9,720,852 | 0% | 1.3% | $59,880,448 |
| Polar Capital Holdings Plc | 4.3% | 9,541,786 | 0% | 0.17% | $58,777,402 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 7,932,545 | +1.9% | 0% | $48,864,477 |
| Nantahala Capital Management, LLC | 3.2% | 6,976,810 | -5% | 2.6% | $42,977,150 |
| STATE STREET CORP | 3% | 6,553,348 | -2.3% | 0% | $40,368,624 |
| MARSHALL WACE, LLP | 2.8% | 6,256,989 | +39% | 0.03% | $38,543,053 |
| RTW INVESTMENTS, LP | 2.7% | 5,952,380 | 0% | 0.31% | $36,666,661 |
| Woodline Partners LP | 1.9% | 4,245,119 | 0% | 0.08% | $26,149,933 |
| ORBIMED ADVISORS LLC | 1.8% | 3,959,900 | +524% | 0.46% | $24,392,984 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 3,872,133 | +7.7% | 0% | $23,857,705 |
| Spruce Street Capital LP | 1.6% | 3,452,576 | +2.1% | 4.2% | $21,267,868 |
| Rosalind Advisors, Inc. | 1.4% | 3,178,121 | -0.8% | 7.4% | $19,577,225 |
| EMERALD ADVISERS, LLC | 1.4% | 3,148,439 | -6.6% | 0.46% | $19,394,384 |
| Pictet Asset Management Holding SA | 1.3% | 2,763,055 | +21% | 0.02% | $17,020,419 |
| Vestal Point Capital, LP | 1.2% | 2,720,000 | +4.6% | 0.39% | $16,755,200 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.2% | 2,694,812 | -0.59% | 0% | $16,600,042 |
| D. E. Shaw & Co., Inc. | 1.1% | 2,514,998 | +19% | 0.01% | $15,492,388 |
| Affinity Asset Advisors, LLC | 1.1% | 2,512,153 | 0% | 0.76% | $15,474,862 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1.1% | 2,375,999 | +0.31% | 0.51% | $14,636,154 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 216,926,914 | $1,336,149,265 | +$28,896,912 | $6.16 | 178 |
| 2026 Q1 | 212,258,088 | $1,158,876,914 | +$54,962,657 | $5.46 | 185 |
| 2025 Q4 | 201,186,328 | $1,213,175,994 | +$226,717,931 | $6.03 | 148 |
| 2025 Q3 | 163,027,204 | $581,865,188 | -$17,744,664 | $3.57 | 124 |
| 2025 Q2 | 167,625,869 | $382,185,936 | +$4,604,999 | $2.28 | 121 |
| 2025 Q1 | 165,084,968 | $457,300,361 | +$4,913,528 | $2.77 | 133 |
| 2024 Q4 | 162,865,251 | $500,000,306 | -$4,524,160 | $3.07 | 134 |
| 2024 Q3 | 160,489,937 | $680,419,874 | +$47,632,176 | $4.24 | 124 |
| 2024 Q2 | 148,167,816 | $597,127,886 | +$107,030,245 | $4.03 | 130 |
| 2024 Q1 | 121,071,712 | $602,921,495 | +$11,975,850 | $4.98 | 119 |
| 2023 Q4 | 118,973,088 | $559,183,072 | +$9,052,732 | $4.70 | 97 |
| 2023 Q3 | 116,727,664 | $441,241,214 | +$105,054,525 | $3.78 | 83 |
| 2023 Q2 | 89,090,177 | $284,756,437 | +$19,803,798 | $3.20 | 76 |
| 2023 Q1 | 83,504,156 | $162,832,384 | +$6,962,703 | $1.95 | 67 |
| 2022 Q4 | 79,984,853 | $123,981,605 | +$92,945 | $1.55 | 52 |
| 2022 Q3 | 79,924,185 | $123,886,636 | +$4,248,900 | $1.55 | 47 |
| 2022 Q2 | 77,190,826 | $117,329,451 | +$2,431,393 | $1.52 | 47 |
| 2022 Q1 | 75,835,578 | $99,344,996 | +$1,530,761 | $1.31 | 45 |
| 2021 Q4 | 74,670,485 | $92,591,002 | -$976,827 | $1.24 | 45 |
| 2021 Q3 | 75,014,959 | $103,530,069 | -$1,889,497 | $1.38 | 54 |
| 2021 Q2 | 76,209,813 | $129,561,285 | +$1,307,097 | $1.70 | 69 |
| 2021 Q1 | 75,191,392 | $156,437,847 | +$111,831,290 | $2.08 | 77 |
| 2020 Q4 | 21,657,964 | $24,908,582 | -$596,543 | $1.15 | 61 |
| 2020 Q3 | 17,084,936 | $18,623,392 | -$4,005,800 | $1.09 | 62 |
| 2020 Q2 | 19,585,868 | $48,753,921 | +$1,741,034 | $2.49 | 68 |